Recombinant Human IL26 Protein，His

Interleukin 26 (IL-26) is a member of the IL-10 cytokine family and plays a significant role in immune responses, particularly in inflammatory pathways associated with autoimmune diseases and microbial infections. Emerging research has demonstrated that IL-26 is primarily produced by T cells, especially Th17 cells, and exhibits various biological functions, including the modulation of innate immune cell activity and the promotion of T cell responses. Its involvement in chronic inflammatory conditions, such as psoriasis and rheumatoid arthritis, has sparked interest in understanding its mechanisms of action. The recombinant expression of IL-26 has become a crucial focus for researchers aiming to explore its potential therapeutic applications. By producing IL-26 in a recombinant form, scientists can study its precise biological activities and interactions with other cytokines and immune cells. Additionally, the recombinant protein can serve as a tool for assessing IL-26’s role in disease models, offering insights into its pathogenic mechanisms. Understanding the structure-function relationship of IL-26 through recombinant proteins may facilitate the development of targeted therapies aimed at modulating its activity, thus holding promise for the treatment of various inflammatory diseases. The ongoing research on recombinant IL-26 is expected to contribute significantly to the fields of immunology and therapeutic design by elucidating its complex roles in the immune system and disease.